Jaguar health launches ai-powered web portal to support patient access to mytesi, the company's fda-approved prescription drug

Ai technology is expected to help make it faster and easier for mytesi® patients to start and stay on the drug san francisco, ca / accesswire / may 10, 2023 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today announced that the company has launched an artificial intelligence-powered web portal for u.s. healthcare professionals to support patient access to mytesi (crofelemer), the company's fda-approved antidiarrheal prescription drug indicated for the symptomatic relief of noninfectious diarrhea in adult patients with hiv/aids on antiretroviral therapy. access to the portal is available to u.s. healthcare professionals on the mytesi healthcare professionals site.
JAGX Ratings Summary
JAGX Quant Ranking